These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Dose-dependent protection by azelastine eye drops against pollen-induced allergic conjunctivitis. A double-blind, placebo-controlled study. Horak F; Berger UE; Menapace R; Toth J; Stübner PU; Marks B Arzneimittelforschung; 1998 Apr; 48(4):379-84. PubMed ID: 9608880 [TBL] [Abstract][Full Text] [Related]
4. Comparison of azelastine eye drops with levocabastine eye drops in the treatment of seasonal allergic conjunctivitis. Giede C; Metzenauer P; Petzold U; Ellers-Lenz B Curr Med Res Opin; 2000; 16(3):153-63. PubMed ID: 11191004 [TBL] [Abstract][Full Text] [Related]
5. Azelastine eye drops reduce conjunctival hyperresponsiveness to hyperosmolar glucose challenge in children with asymptomatic mite conjunctivitis. Ciprandi G; Catrullo A; Tosca M; Cerqueti P; Mondino C; Passalacqua G; Canonica GW J Investig Allergol Clin Immunol; 1999; 9(1):35-8. PubMed ID: 10212855 [TBL] [Abstract][Full Text] [Related]
6. [Allergodil eye drops in the treatment of allergic conjunctivitis]. Haicl P; Cerná H Cesk Slov Oftalmol; 2002 Jul; 58(4):254-8. PubMed ID: 12181881 [TBL] [Abstract][Full Text] [Related]
7. [Ketotifen fumarate (Zaditen) eye drops in the treatment of seasonal allergic conjunctivitis]. Haicl P; Cerná H Cesk Slov Oftalmol; 2004 Sep; 60(5):362-7. PubMed ID: 15566225 [TBL] [Abstract][Full Text] [Related]
9. Double-blind, randomised, placebo-controlled study of two concentrations of azelastine eye drops in seasonal allergic conjunctivitis or rhinoconjunctivitis. Lenhard G; Mivsek-Music E; Perrin-Fayolle M; Obtulowicz K; Secchi A Curr Med Res Opin; 1997; 14(1):21-8. PubMed ID: 9524790 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial. Avunduk AM; Tekelioglu Y; Turk A; Akyol N Clin Ther; 2005 Sep; 27(9):1392-402. PubMed ID: 16291412 [TBL] [Abstract][Full Text] [Related]
11. Azelastine eye-drops in seasonal allergic conjunctivitis or rhinoconjunctivitis. A double-blind, randomized, placebo-controlled study. Giede-Tuch C; Westhoff M; Zarth A Allergy; 1998 Sep; 53(9):857-62. PubMed ID: 9788686 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of topical azelastine compared with topical mitomycin C in patients with allergic conjunctivitis. Sodhi PK; Pandey RM; Ratan SK Cornea; 2003 Apr; 22(3):210-3. PubMed ID: 12658084 [TBL] [Abstract][Full Text] [Related]
15. [Respiratory allergies in the child and the adult]. Magnan A Rev Prat; 2004 Jan; 54(2):189-98. PubMed ID: 15086062 [No Abstract] [Full Text] [Related]
16. Azelastine (Astepro) nasal spray for allergic rhinitis. Med Lett Drugs Ther; 2009 Apr; 51(1310):29-30. PubMed ID: 19377406 [No Abstract] [Full Text] [Related]
17. A comparison of the clinical efficacy of pheniramine maleate/naphazoline hydrochloride ophthalmic solution and olopatadine hydrochloride ophthalmic solution in the conjunctival allergen challenge model. Greiner JV; Udell IJ Clin Ther; 2005 May; 27(5):568-77. PubMed ID: 15978305 [TBL] [Abstract][Full Text] [Related]
18. Topical bromfenac sodium for long-term management of vernal keratoconjunctivitis. Uchio E; Itoh Y; Kadonosono K Ophthalmologica; 2007; 221(3):153-8. PubMed ID: 17440276 [TBL] [Abstract][Full Text] [Related]
19. Azelastine does not adversely affect aerobic performance. Chicharro JL; Lucía A; Vaquero AF; Pérez M J Sports Med Phys Fitness; 1998 Sep; 38(3):266-71. PubMed ID: 9830837 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial. Borazan M; Karalezli A; Akova YA; Akman A; Kiyici H; Erbek SS Acta Ophthalmol; 2009 Aug; 87(5):549-54. PubMed ID: 18631332 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]